Latest Annexin Pharmaceuticals News & Updates

See the latest news and media coverage for Annexin Pharmaceuticals. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Annexin Pharmaceuticals

Clinical-stage biotechnology company developing Annexin A5 therapeutics

annexinpharma.com
Headquarters
Stockholm, Sweden
Founded year
2014
Company type
Public company
Number of employees
5–10

Last updated

Latest news about Annexin Pharmaceuticals

In short: Annexin Pharmaceuticals reported promising results in its clinical trials for ANXV and secured several rounds of financing to fund its R&D activities.

Company announcements

  • Annexin Pharmaceuticals

    Annexin accelerates patient recruitment in NEXUS study

    Five patients treated for RVO and DR with no safety issues. Promising initial results observed. Recruitment continues.

  • Annexin Pharmaceuticals

    Annexin Pharmaceuticals secures bridge loan and plans rights issue

    They obtain a SEK 4 million bridge loan and plan a SEK 20 million rights issue to fund Phase 2a NEXUS; major shareholders committed about SEK 12 million.

  • Annexin Pharmaceuticals

    Annexin Pharmaceuticals advances ANXV in ophthalmology

    Expands into diabetic retinopathy with Prof. Paulo Eduardo Stanga's team at The Retina Clinic London.

  • Annexin Pharmaceuticals

    Annexin announces favourable findings in Phase 2a study

    First two patients with DR and RVO show no safety issues and signals of efficacy including improved retinal perfusion after ANXV treatment. Study prepares for Phase 2b.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Annexin Pharmaceuticals

Track Annexin Pharmaceuticals and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.